Pediatric Long-Term Follow-up and Rollover Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

June 23, 2026

Study Completion Date

July 23, 2026

Conditions
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytomaOligodendroglioma, ChildhoodAnaplastic OligodendrogliomaGlioblastomaPilocytic AstrocytomaGiant Cell AstrocytomaPleomorphic XanthoastrocytomaAnaplastic Pleomorphic XanthoastrocytomaAngiocentric GliomaChordoid Glioma of Third VentricleGangliocytomaGangliogliomaAnaplastic GangliogliomaDysplastic Gangliocytoma of CerebrellumDesmoplastic Infantile Astrocytoma and GangliogliomaPapillary Glioneuronal TumorRosette-forming Glioneuronal TumorCentral NeurocytomaExtraventricular NeurocytomaCerebellar LiponeurocytomaNeurofibromatosis Type 1
Interventions
DRUG

dabrafenib

dabrafenib oral, twice daily

DRUG

trametinib

trametinib oral, once daily

Trial Locations (55)

1200

Novartis Investigative Site, Brussels

2010

Novartis Investigative Site, Darlinghurst

3052

Novartis Investigative Site, Parkville

10065

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Cancer Ctr, New York

10126

Novartis Investigative Site, Torino

13353

Novartis Investigative Site, Berlin

13885

Novartis Investigative Site, Marseille

16147

Novartis Investigative Site, Genova

17176

Novartis Investigative Site, Stockholm

20010

Childrens National Hospital, Washington D.C.

20133

Novartis Investigative Site, Milan

20246

Novartis Investigative Site, Hamburg

21287

Johns Hopkins Hospital, Baltimore

28009

Novartis Investigative Site, Madrid

29609

Novartis Investigative Site, Brest

33155

Nicklaus Childrens Hospital, Miami

33521

Novartis Investigative Site, Tampere

35000

Novartis Investigative Site, Rennes

35203

Novartis Investigative Site, Rennes

38105

St Jude Childrens Research Hospital, Memphis

45147

Novartis Investigative Site, Essen

46026

Novartis Investigative Site, Valencia

50139

Novartis Investigative Site, Florence

50937

Novartis Investigative Site, Cologne

54511

Novartis Investigative Site, Vandœuvre-lès-Nancy

55455

University of Minnesota, Minneapolis

75231

Novartis Investigative Site, Paris

77030

Texas Childrens Hospital, Houston

85016

Phoenix Children s Hospital, Phoenix

86179

Novartis Investigative Site, Augsburg

94800

Novartis Investigative Site, Villejuif

117198

Novartis Investigative Site, Moscow

4920235

Novartis Investigative Site, Petah Tikva

46202-2810

Indiana Uni School of Medicine, Indianapolis

02215

Dana Farber Cancer Institute, Boston

45229-3039

Cinn Children Hosp Medical Center, Cincinnati

C1428AQK

Novartis Investigative Site, CABA

14784 400

Novartis Investigative Site, Barretos

04829-310

Novartis Investigative Site, São Paulo

08270-070

Novartis Investigative Site, São Paulo

V6H 3V4

Novartis Investigative Site, Vancouver

M5G 1X8

Novartis Investigative Site, Toronto

H3T 1C5

Novartis Investigative Site, Montreal

625 00

Novartis Investigative Site, Brno

150 06

Novartis Investigative Site, Prague

DK-2100

Novartis Investigative Site, Copenhagen

00165

Novartis Investigative Site, Roma

157-8535

Novartis Investigative Site, Setagaya-ku

534-0021

Novartis Investigative Site, Osaka

3584 CS

Novartis Investigative Site, Utrecht

SM2 5PT

Novartis Investigative Site, Sutton

L12 2AP

Novartis Investigative Site, Liverpool

NW1 2BU

Novartis Investigative Site, London

WC1N 3JH

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY